FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, and concerns a solid or semi-liquid pharmaceutical dosage form containing a non-steroid anti-inflammatory drug, namely a propionic acid derivative - ibuprofen together with a second active ingredient having a shorter period of a therapeutically effective plasma concentration, namely Phenylephrine, and a method for introducing it.
EFFECT: invention provides an intensified therapeutic effects, particularly pain control together with decongestion for a longer period of time.
25 cl, 15 ex, 9 tbl
